Business
Kneat Contracts with Global Healthcare Company
Kneat Contracts with Global Healthcare Company Canada NewsWire HALIFAX, July 12,...
About this update from Kneat.com, Inc.
[{"type":"text","content":"\n\n\n\nKneat Contracts with Global Healthcare Company\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nHALIFAX, July 12, 2018\n\n\n\nHALIFAX, July 12, 2018 /CNW/ - kneat.com, inc. (TSXV: KSI) (\"Kneat\") is pleased to announce its fourth new top tier customer win of 2018. One of the world's leading research-based developers of pharmaceuticals has chosen Kneat's technology to digitize its commissioning, qualification and validation processes. After historically using paper-based processes, this customer is transitioning to 100% digital to enable consistency, visibility and data integrity across its manufacturing sites. The initial scope of this on-premise license and maintenance agreement is for global capital projects with the opportunity to scale to other processes across multiple sites over several years. This tier one pharmaceutical company has more than 70 manufacturing plants and 90,000 employees operating in over 120 countries.\n\n\"We look forward to working closely with this customer to standardize and digitally transform their commissioning, qualification and validation processes globally over the coming years.\" said Eddie Ryan, Chief Executive Officer of Kneat.  \n\nKneat continues to expand its customer pipeline and will report on further developments as they occur.\n\nAbout Kneat\n\nKneat develops and markets the next generation Kneat Gx software platform. Multiple business processes can be configured on the platform from equipment to computer system validation, through to quality document management. Kneat's software allows users to author, review, approve, execute testing online, manage any exceptions and post approve final deliverables in a controlled FDA 21 CFR Part 11/ Eudralex Annex 11 compliant platform. Macro and micro report dashboards enable powerful oversight into all systems, projects and processes world wide. Customer case studies are reporting productivity improvements in excess of 100% and a higher data integrity and compliance standard. For more information visit www.kneat.com.\n\nCautionary an...